Overview

Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere)

Status:
Terminated

Trial end date:
2008-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine if the addition of motexafin gadolinium (study drug) to standard treatment with docetaxel will improve the response rate in patients with non-small cell lung cancer.

Phase:

Phase 2

Details

Lead Sponsor:

Pharmacyclics LLC.

Treatments:

Docetaxel
Motexafin gadolinium